Updates in MASLD

Overview

Fatty liver disease affects millions and the science is evolving rapidly. Join us for a high-yield session covering the latest nomenclature updates, risk stratification tools, and breakthrough therapeutic options. Walk away with actionable strategies to identify at-risk patients earlier, assess fibrosis with confidence, and stay ahead of the curve in managing steatotic liver disease.

Learning Objectives

• As a result of participating in this activity, learners will be able to identify risk factors for development of steatotic liver disease
• As a result of participating in this activity, learners will be able to apply non-invasive testing strategies to screen for steatotic liver disease and chronic liver disease
• As a result of participating in this activity, learners will be able to apply interventions to treat steatotic liver disease and prevent disease progression